RVNC DEADLINE TOMORROW: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Revance Therapeutics, Inc. Investors to Secure Counsel Before Important March 4 Deadline in Securities Class Action – RVNC
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 03 2025
0mins
Source: Globenewswire
Class Action Reminder: Rosen Law Firm is reminding investors who purchased Revance Therapeutics securities between February 29, 2024, and December 6, 2024, of the March 4, 2025, deadline to join a class action lawsuit for potential compensation without upfront costs.
Allegations Against Revance: The lawsuit claims that Revance made misleading statements regarding its agreements and risks, which led to investor damages when the truth was revealed.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
